Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,661 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control study.
Cheng AC, Kotsimbos T, Kelly HA, Irving LB, Bowler SD, Brown SG, Holmes M, Jenkins CR, Thompson P, Simpson G, Wood-Baker R, Senanayake SN, Brady SJ, Paterson DL, Wark PA, Upham JW, Korman TM, Dwyer DE, Waterer GW, Kelly PM. Cheng AC, et al. Among authors: thompson p. Vaccine. 2011 Oct 6;29(43):7320-5. doi: 10.1016/j.vaccine.2011.07.087. Epub 2011 Jul 31. Vaccine. 2011. PMID: 21810450
Influenza A/H1N1_09: Australia and New Zealand's winter of discontent.
Kotsimbos T, Waterer G, Jenkins C, Kelly PM, Cheng A, Hancox RJ, Holmes M, Wood-Baker R, Bowler S, Irving L, Thompson P; Thoracic Society of Australia and New Zealand H1N1 Influenza 09 Task Force. Kotsimbos T, et al. Among authors: thompson p. Am J Respir Crit Care Med. 2010 Feb 15;181(4):300-6. doi: 10.1164/rccm.200912-1878CP. Am J Respir Crit Care Med. 2010. PMID: 20130145
Clinical and epidemiological profile of patients with severe H1N1/09 pandemic influenza in Australia and New Zealand: an observational cohort study.
Cheng AC, Kotsimbos T, Reynolds A, Bowler SD, Brown SG, Hancox RJ, Holmes M, Irving L, Jenkins C, Thompson P, Simpson G, Waterer G, Wood-Baker R, Kelly PM. Cheng AC, et al. Among authors: thompson p. BMJ Open. 2011 Jul 20;1(1):e000100. doi: 10.1136/bmjopen-2011-000100. BMJ Open. 2011. PMID: 22021761 Free PMC article.
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).
McElvaney NG, Burdon J, Holmes M, Glanville A, Wark PA, Thompson PJ, Hernandez P, Chlumsky J, Teschler H, Ficker JH, Seersholm N, Altraja A, Mäkitaro R, Chorostowska-Wynimko J, Sanak M, Stoicescu PI, Piitulainen E, Vit O, Wencker M, Tortorici MA, Fries M, Edelman JM, Chapman KR; RAPID Extension Trial Group. McElvaney NG, et al. Among authors: thompson pj. Lancet Respir Med. 2017 Jan;5(1):51-60. doi: 10.1016/S2213-2600(16)30430-1. Epub 2016 Dec 2. Lancet Respir Med. 2017. PMID: 27916480 Clinical Trial.
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.
Serisier DJ, Bilton D, De Soyza A, Thompson PJ, Kolbe J, Greville HW, Cipolla D, Bruinenberg P, Gonda I; ORBIT-2 investigators. Serisier DJ, et al. Among authors: thompson pj. Thorax. 2013 Sep;68(9):812-7. doi: 10.1136/thoraxjnl-2013-203207. Epub 2013 May 16. Thorax. 2013. PMID: 23681906 Free PMC article. Clinical Trial.
6,661 results